骨化三醇作用機(jī)制 - Medchemexpress - MCE中國_第1頁
骨化三醇作用機(jī)制 - Medchemexpress - MCE中國_第2頁
骨化三醇作用機(jī)制 - Medchemexpress - MCE中國_第3頁
全文預(yù)覽已結(jié)束

骨化三醇作用機(jī)制 - Medchemexpress - MCE中國.docx 免費(fèi)下載

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Product Data SheetCalcitriolCat. No.: HY-10002CAS No.: 32222-06-3分式: CHO分量: 416.64作靶點(diǎn): VD/VDR; Endogenous Metabolite作通路: Vitamin D Related; Metabolic Enzyme/Protease儲(chǔ)存式: -20C, protect from light, stored under nitrogen* In solvent : -80C, 6 months; -20C, 1 month (protect from light, stored undernitro

2、gen)溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (240.02 mM)* means soluble, but saturation unknown.SolventMass1 mg 5 mg 10 mgConcentration制備儲(chǔ)備液1 mM 2.4002 mL 12.0008 mL 24.0015 mL5 mM 0.4800 mL 2.4002 mL 4.8003 mL10 mM 0.2400 mL 1.2001 mL 2.4002 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存式和期限:-80C

3、, 6 months; -20C, 1 month (protect from light, stored under nitrogen)。-80C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)內(nèi)使,-20C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)內(nèi)使。體內(nèi)實(shí)驗(yàn)請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍浮R韵氯芙獍付颊?qǐng)先按照 In Vitro 式配制澄清的儲(chǔ)備液,再依次添加助溶劑:為保證實(shí)驗(yàn)結(jié)果的可靠性,澄 的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使; 以下溶劑前顯的百分 指該溶劑在您配制終溶液中的體積占;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的式助溶1. 請(qǐng)依序添加每種溶劑: 10%

4、DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.00 mM); Clear solution此案可獲得 2.5 mg/mL (6.00 mM,飽和度未知) 的澄清溶液。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 400 L PEG300 中,混合均勻;向上述體系中加50 L Tween-80,混合均勻;然后繼續(xù)加 450 L 理鹽定容 1 mL。2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5

5、 mg/mL (6.00 mM); Clear solution此案可獲得 2.5 mg/mL (6.00 mM,飽和度未知) 的澄清溶液。Page 1 of 2 www.MedChemE以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄均勻。DMSO 儲(chǔ)備液加到 900 L 20% 的 SBE-CD 理鹽溶液中,混合3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (6.00 mM); Clear solution此案可獲得 2.5 mg/mL (6.00 mM,飽和度未知) 的澄 溶液,此案不適于實(shí)驗(yàn)周 期在半

6、個(gè)以上的實(shí)驗(yàn)。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 900 L 油中,混合均勻。BIOLOGICAL ACTIVITY物活性 Calcitriol活性最的 vitamin D 代謝物,也是vitamin D 受體 (VDR) 的激動(dòng)劑。IC & Target Human Endogenous Metabolite體外研究 Calcitriol exerts antiproliferative effects on cervical cancer cells in vitro. Cells decrease by 12.8% when trea

7、ted with 100nM Calcitriol for 6 days, compare with control. Inhibition of cell proliferation becomes more pronounced with theincrease in Calcitriol concentration. The decrease is 26.1% and 31.6% for 200 and 500 nM Calcitriol, respectively.Treatment with Calcitriol for 72 h induces an evident accumul

8、ation of cells in the G1 phase, with approximately66.18% in 200 nM and 78.10% in 500 nM, compare with the control (24.36%). Calcitriol treatment significantlydecreases HCCR-1 protein expression compare with the control in a time- and dose-dependent manner1. Calcitriolsignificantly increases ER mRNA

9、in a dose dependent manner with an EC50 of 9.810-9 M2.體內(nèi)研究 Chronic treatment with Calcitriol (150 ng/kg per day for 4.5 months) improves the relaxations (pD2: 6.300.09, Emax:68.63.9% in Calcitriol-treated OVX, n=8). Renal blood flow in OVX rats is reduced in both kidneys, and the flow isrestored by

10、Calcitriol treatment. The increased expression of COX-2 and Thromboxane-prostanoid (TP) receptor inOVX rat renal arteries is reduced by chronic calcitriol administration3. High- and low-dose Calcitriol treatmentsignificantly decreases the systolic blood pressure (SBP) in the fructose-fed rats by 144

11、 and 94 mmHg, respectively,at Day 56. High-dose Calcitriol treatment (20 ng/kg per day) significantly increases serum ionized calcium level(1.440.05 mmol/L) compare with the other groups4.PROTOCOLCell Assay 1 HeLa S3 cells are plated at a density of 1,000 cells/well in 96-well plates of Dulbeccos mo

12、dified Eagles medium(DMEM) with 10% fetal bovine serum (FBS), treated with 1% ethanol (control) or various concentrations of Calcitriol (100, 200, and 500 nM) for 72 h. A Cell Counting Kit8 (CCK-8) is used to determine cell proliferation. At 24, 48, 72, 96,120, and 144 h after culturing with 200 nM

13、Calcitriol, cells are harvested for analysis. Three independent experimentsare performed in quadruplicate1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Adult female Sprague-Dawley rats weighing 200 to 220g are used in this study. Rats are hous

14、ed in a temperature-Administration 3 controlled room (23C) with a 12-h light/dark cycle. The animals have free access to a standard diet and water.Ovariectomy (OVX) is performed on rats. At 6 months after the surgical procedure, the OVX rats are randomlyassigned to either treatment with vehicle dime

15、thyl sulfoxide (OVX+vehicle) or Calcitriol (150 ng/kg daily,OVX+calcitriol). Calcitriol treatment is given by oral gavage and lasted or 4.5 months. Blood pressure and serumCalcitriol level are measured3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Pa

16、ge 2 of 3 www.MedChemE戶使本產(chǎn)品發(fā)表的科研獻(xiàn) J Lipid Res. 2019 Mar 22. pii: jlr.D092197. J Steroid Biochem Mol Biol. 2017 Oct;173:341-348. Cell Signal. 2020 Feb 6:109567. Int Immunopharmacol. 2017 Apr 13;47:182-189. Biomed Chromatogr. 2020 Jan 3:e4783.See more customer validations on HYPERLINK www.MedChemE www

17、.MedChemEREFERENCES1. Wang G, et al. Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression. Oncol Res. 2014;22(5-6):301-9.2. Santos-Martnez N, et al. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a poten

18、tial new therapeuticapproach. BMC Cancer. 2014 Mar 29;14:230.3. Dong J, et al. Calcitriol restores renovascular function in estrogen-deficient rats through downregulation of cyclooxygenase-2 and the thromboxane-prostanoid receptor. Kidney Int. 2013 Jul;84(1):54-63.4. Chou CL, et al. Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, andvisceral adiposity in fructose-fe

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論